Skip to main content
Jon Giles, MD, Rheumatology, Los Angeles, CA

JonTylerGilesMDMPH

Rheumatology Los Angeles, CA

Columbia University College of Physicians & Surgeons

Dr. Giles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Giles' full profile

Already have an account?

  • Office

    8723 Alden Dr
    Los Angeles, CA 90048
    Phone+1 310-423-6257
    Fax+1 310-423-6287

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Rheumatology, 2002 - 2004
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Internal Medicine, 1998 - 2001
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2024 - 2026
  • NY State Medical License
    NY State Medical License 2010 - 2024
  • MD State Medical License
    MD State Medical License 2004 - 2012
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • Amygdalar Metabolic Activity Independently Associates with Progression of Visceral Adiposity  
    Steven K Grinspoon, Janet Lo, Jon T Giles, Lisa M Shin, Karestan C Koenen, Roger K Pitman, Ahmed Tawakol, The Journal of Clinical Endocrinology and Metabolism

Press Mentions

  • Basic & Clinical Research Conference to Explore Dynamics of Inflammation and Cardiovascular Risk
    Basic & Clinical Research Conference to Explore Dynamics of Inflammation and Cardiovascular RiskNovember 8th, 2024
  • Statin Use Key to Reducing CV Risk in Rheumatoid Arthritis Patients on Tofacitinib: ORAL Surveillance Analysis
    Statin Use Key to Reducing CV Risk in Rheumatoid Arthritis Patients on Tofacitinib: ORAL Surveillance AnalysisSeptember 24th, 2023
  • ACR 2022: The Safety of JAK Inhibitors in Rheumatology
    ACR 2022: The Safety of JAK Inhibitors in RheumatologyNovember 26th, 2022
  • Join now to see all

Grant Support

  • Determinats Of Body Composition In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010
  • Determinats Of Body Composition In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2006–2009